Question explored with the scientific record
Colonoscopy needed
The short version: colonoscopy is a diagnostic tool with real risks and a benefit that depends entirely on your individual risk profile, not on a blanket recommendation.
The evidence for colonoscopy as a screening tool is built on a foundation of sand. The only randomized trials that show a reduction in colorectal cancer mortality are for guaiac FOBT (18% relative reduction, number needed to screen 377) and flexible sigmoidoscopy (26% reduction, NNS 864) [1]. There is no randomized trial showing that colonoscopy itself reduces colorectal cancer mortality or all-cause mortality [1]. The entire screening colonoscopy enterprise rests on observational data and the assumption that finding and removing polyps must help, an assumption that has never been proven in a randomized controlled trial. The largest screening colonoscopy study in the evidence, with 11,808 procedures, found 272 cancers (2.3%) and 16 complications within 30 days, including 2 perforations and 5 bleeds [10]. That is a 0.14% immediate complication rate in a screening population, but the long-term benefit is unmeasured against a true control group.
The risks are real and dose-dependent. A therapeutic colonoscopy (with polypectomy) carries a 9.2-fold higher risk of serious complications than a diagnostic one [2]. In a large Japanese study of 345,546 therapeutic procedures, the death rate was 1.32 per 1,000 patients, with bleeding in 3.25% and perforation in 0.047% [5]. The sedation itself is not harmless: even in screening, 15.4% of patients experienced hypotension and 9.9% hypoxia [7]. An anesthesia professional does not reduce serious adverse events for colonoscopy (OR 0.93, CI 0.82-1.06) [16].
| Outcome | Screening colonoscopy | Therapeutic colonoscopy |
|---|---|---|
| Bleeding | 0.04% [10] | 3.25% [5] |
| Perforation | 0.02% [10] | 0.047% [5] |
| Death within 30 days | 0% [10] | 0.13% [5] |
| Any serious complication | 0.14% [10] | 0.5% [2] |
My call: for an asymptomatic average-risk person, the evidence does not show that colonoscopy reduces your chance of dying from any cause, and the procedure carries measurable risks of bleeding, perforation, and sedation-related events. The burden of proof for a healthy person to accept this intervention has not been met. Confidence: moderate, because the absence of randomized evidence for colonoscopy is a genuine gap, not a settled question.
Sources examined 16
-
Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis evaluates the effectiveness and harms of colorectal cancer (CRC) screening in asymptomatic adults, synthesizing randomized trials of guaiac FOBT (gFOBT), immunochemical FOBT (iFOBT), and flexible sigmoidoscopy (FS); it finds reductions in…
DOI: 10.1016/j.clcc.2016.03.003 -
Complications of Colonoscopy in an Integrated Health Care Delivery System
A population-based retrospective cohort study in Kaiser Permanente Northern California quantified serious complications within 30 days after colonoscopy, showing that biopsy or polypectomy markedly increases risk and that screening procedures have very low complication rates.
DOI: 10.7326/0003-4819-145-12-200612190-00004 -
Acute abdominal compartment syndrome with pulseless electrical activity during colonoscopy with conscious sedation
This case report describes an episode of acute abdominal compartment syndrome with pulseless electrical activity in a 79-year-old male patient during a colonoscopy, highlighting the physiological consequences of increased intra-abdominal pressure and the importance of timely int…
DOI: 10.1016/s0952-8180(00)00140-9 -
Systematic review with meta‐analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation
A comprehensive systematic review and meta-analysis of 168 clinical studies of faecal microbiota transplantation (FMT) that characterizes donor features, screening procedures, delivery routes, indications (notably CDI and IBD), and associated outcomes and adverse events to infor…
DOI: 10.1111/apt.15116 -
Factors predicting adverse events associated with therapeutic colonoscopy for colorectal neoplasia: a retrospective nationwide study in Japan
This study investigates the factors predicting adverse events such as bleeding and bowel perforation associated with therapeutic colonoscopy for colorectal neoplasia using a large nationwide database in Japan.
DOI: 10.1016/j.gie.2016.05.013 -
Efficacy and safety of etomidate–midazolam for screening colonoscopy in the elderly
This study investigates the efficacy and safety of etomidate-midazolam compared to propofol-midazolam for screening colonoscopy in elderly patients, finding that etomidate-midazolam is associated with fewer cardiopulmonary adverse events.
DOI: 10.1097/MD.0000000000010635 -
Canadian Association of Gastroenterology Indicators of Safety Compromise following Colonoscopy in Clinical Practice
This study assessed the incidence of 19 indicators of safety compromise following colonoscopy in St. John's, NL, revealing that while most adverse events were mild and sedation-related, the rates of serious adverse events were consistent with published reports.
DOI: 10.1155/2016/2729871 -
DIFFERENT SEGMENTAL TRANSIT TIME (TT) THROUGH THE SMALL BOWEL MAY AFFECT WIRELESS CAPSULE (WC) ENDOSCOPY
This study evaluates the satisfaction and adverse events associated with two different regimens of PillCam Colon Capsule Endoscopy (PCCE) compared to standard colonoscopy (SC) in a cohort of patients, finding no significant differences in satisfaction or adverse events between t…
DOI: 10.1016/s1590-8658(09)60411-4 -
Comparison of the accuracy of CT colonography and colonoscopy in the diagnosis of colorectal cancer
A systematic review and meta-analysis comparing CT colonography with conventional colonoscopy for colorectal cancer screening in asymptomatic average-risk adults, finding CT colonography has high specificity but more variable sensitivity, with better performance for larger polyp…
DOI: 10.1111/codi.12506 -
Incidental Finding of Colorectal Cancer in Screening Colonoscopy and Its Cost Effectiveness
Screening colonoscopy in asymptomatic adults over 50 detects notable colorectal neoplasia, including proximal cancers, with low short-term complication rates and favorable cost-effectiveness compared with alternative screening methods, supporting colonoscopy as a primary screeni…
DOI: 10.1177/000313480907500811 -
A RARE PRESENTATION OF UC FLARE ASSOCIATED WITH ROTAVIRUS INFECTION
A large propensity score–matched retrospective study using national data shows that patients with quiescent inflammatory bowel disease (IBD) have a higher risk of receiving steroid prescriptions within 30 days after surveillance colonoscopy compared with non-IBD controls, sugges…
DOI: 10.1093/ibd/izae282.042 -
Effect of Endocuff-assisted colonoscopy on adenoma detection rate: meta-analysis of randomized controlled trials
This meta-analysis of randomized controlled trials demonstrates that Endocuff-assisted colonoscopy significantly improves adenoma detection rates, particularly among operators with low-to-moderate adenoma detection rates, without increasing adverse events.
DOI: 10.1055/a-0577-3500 -
A randomized, controlled trial of oral sulfate solution plus polyethylene glycol as a bowel preparation for colonoscopy
Two randomized, single-blind trials show that a hybrid bowel preparation consisting of a reduced-dose oral sulfate solution plus 2 L of sulfate-free electrolyte lavage solution is noninferior to standard low-volume PEG-ELS and noninferior to bisacodyl plus SF-ELS for colon clean…
DOI: 10.1016/j.gie.2014.03.043 -
Patient-reported complications related to colonoscopy: a prospective feasibility study of an email-based survey
A prospective feasibility study evaluating an email-based online questionnaire to capture patient-reported minor complications after outpatient colonoscopy, showing good initial response rates but underestimation of minor events and some sick leave.
DOI: 10.1080/0284186x.2018.1535188 -
Seven-day postcolonoscopy emergency department visits: What do they really measure?
Editorial analysis arguing that 7-day postcolonoscopy emergency department visits do not accurately measure colonoscopy quality and should be complemented by focusing on definite adverse events within a 14-day window, using direct case adjudication to distinguish avoidable from …
DOI: 10.1016/j.gie.2017.10.023 -
Patient safety during sedation by anesthesia professionals during routine upper endoscopy and colonoscopy: an analysis of 1.38 million procedures
ADS does not reduce SAEs in colonoscopy and increases SAE risk in EGD for ASA I–III patients, offering no overall safety benefit for ADS in routine endoscopy.
DOI: 10.1016/j.gie.2016.02.007